Facebook
Twitter
LinkedIn
Forward
Up to 90% of patients with obesity are affected by MASLD, with a sizable portion at risk for progressing to MASH and liver fibrosis.
|
For decades, the recommended treatment for obesity seemed to be just "eat less." Eat less fat. Eat less sugar. Eat less red meat. Eat less overall.
|
This session presents practical ways using patient case scenarios to integrate current artificial intelligence technologies into obesity care delivery to help scale high quality evidence based care
|
In this lecture, attendees will learn to identify key factors in a patient’s history that can impact obesity treatment outcomes.
|
This session will explore how women are uniquely impacted by the complex relationship between sarcopenia (loss of muscle mass) and obesity.
|
This session will provide an in-depth review of updated ICD-10 and CPT codes related to obesity management, including guidance on proper documentation to support medical necessity and coverage.
|
This session will explore the various career options in the field of obesity medicine.
|
This session will explore strategies for marketing an obesity medicine practice in today’s complex social media landscape.
|
Explore the transformative power of advocacy in obesity medicine.
|
This panel discussion will explore the current state of access and quality of care for patients with obesity, focusing on the complexities within the healthcare system and coverage options.
|